Literature DB >> 8307075

Treatment system for nocturnal enuresis according to an original classification system.

H Watanabe1, A Kawauchi, T Kitamori, Y Azuma.   

Abstract

Our department has reported recent studies for nocturnal enuresis. The morning bladder capacity in enuretic children was smaller in the 3- and 4-year-old age range but larger in the 7-year and over age range than that in nonenuretic children. 15% of nonenuretic children showed nocturnal polyuria with nocturnal urination after complete awakening more than once per week. It was not likely from this evidence that an immature bladder capacity or nocturnal polyuria was the primary cause of enuresis. Patients with enuresis were classified into three types based on overnight simultaneous monitoring by electroencephalography and cystometry. The pathogenesis of enuresis type I and type IIa was a disturbance of awakening, while that of type IIb was a disturbance of bladder function not shown in the daytime but only at night. An original systematic therapeutic plan was established with the development of an original therapeutic machine primarily for enuresis type I.

Entities:  

Mesh:

Year:  1994        PMID: 8307075     DOI: 10.1159/000475246

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

Review 1.  Current perspectives on the correlation of nocturnal enuresis with obstructive sleep apnea in children.

Authors:  Miao-Shang Su; Li Xu; Wen-Feng Pan; Chang-Chong Li
Journal:  World J Pediatr       Date:  2018-11-16       Impact factor: 2.764

Review 2.  Cure of nocturnal enuresis: why isn't desmopressin very effective?

Authors:  S A Koff
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

3.  Nocturnal enuresis.

Authors:  S Aneja
Journal:  Indian J Pediatr       Date:  2002-08       Impact factor: 1.967

4.  Practical consensus guidelines for the management of enuresis.

Authors:  Johan Vande Walle; Soren Rittig; Stuart Bauer; Paul Eggert; Daniela Marschall-Kehrel; Serdar Tekgul
Journal:  Eur J Pediatr       Date:  2012-02-24       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.